Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$633M |
| 2 |
Willis Towers Watson
WTW
|
+$528M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$525M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$431M |
| 5 |
AGN
Allergan plc
AGN
|
+$384M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.17B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
iShares Biotechnology ETF
IBB
|
+$352M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$339M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.73% |
| 2 | Healthcare | 5.73% |
| 3 | Financials | 5.39% |
| 4 | Consumer Discretionary | 4.7% |
| 5 | Communication Services | 4.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
CALL
Ionis Pharmaceuticals
IONS
$8.6B
| $435K | ﹤0.01% |
9,200
-19,400
| -68% | -$1.08M |
|
3927
Varex Imaging
VREX
$472M
| $435K | ﹤0.01% |
19,128
-50,180
| -72% | -$1.29M |
|
|
HZNP
3928
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $435K | ﹤0.01% |
14,700
-6,900
| -32% | -$233K |
|
3929
Vertiv
VRT
$93B
| $434K | ﹤0.01% |
50,151
-224,849
| -82% | -$2.48M |
|
|
GRA
3930
PUT
DELISTED
W.R. Grace & Co.
GRA
| $434K | ﹤0.01% |
12,200
-12,900
| -51% | -$737K |
|
3931
Nuveen Quality Municipal Income Fund
NAD
$2.74B
| $433K | ﹤0.01% |
31,528
-24,265
| -43% | -$351K |
|
3932
CALL
Diageo
DEO
$49B
| $432K | ﹤0.01% |
3,400
+1,500
| +79% | +$225K |
|
3933
WisdomTree International SmallCap Dividend Fund
DLS
$1.06B
| $432K | ﹤0.01% |
8,985
+906
| +11% | +$56.5K |
|
3934
Theravance Biopharma
TBPH
$874M
| $432K | ﹤0.01% |
18,675
+4,951
| +36% | +$124K |
|
|
EIGR
3935
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $432K | ﹤0.01% |
2,118
+1,894
| +846% | +$604K |
|
3936
CALL
Genuine Parts
GPC
$17.1B
| $431K | ﹤0.01% |
6,400
+4,100
| +178% | +$365K |
|
3937
nLIGHT
LASR
$3.88B
| $431K | ﹤0.01% |
41,121
+30,913
| +303% | +$527K |
|
3938
CALL
Sunrun
RUN
$2.34B
| $431K | ﹤0.01% |
42,700
-26,800
| -39% | -$440K |
|
|
YMAB
3939
DELISTED
Y-mAbs Therapeutics
YMAB
| $431K | ﹤0.01% |
16,510
-1,061
| -6% | -$30.8K |
|
|
CBPO
3940
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $431K | ﹤0.01% |
3,993
-5,980
| -60% | -$687K |
|
3941
PUT
SSR Mining
SSRM
$5.32B
| $430K | ﹤0.01% |
38,100
+3,100
| +9% | +$51K |
|
3942
Warrior Met Coal
HCC
$4.19B
| $428K | ﹤0.01% |
40,301
-28,281
| -41% | -$511K |
|
|
PVG
3943
PUT
DELISTED
PRETIUM RESOURCES INC.
PVG
| $428K | ﹤0.01% |
75,800
-14,000
| -16% | -$120K |
|
|
I
3944
CALL
DELISTED
INTELSAT S. A.
I
| $428K | ﹤0.01% |
279,400
-137,100
| -33% | -$574K |
|
3945
CALL
Kratos Defense & Security Solutions
KTOS
$8.74B
| $426K | ﹤0.01% |
30,800
+6,100
| +25% | +$105K |
|
3946
National Healthcare
NHC
$3.53B
| $426K | ﹤0.01% |
5,937
+2,811
| +90% | +$222K |
|
|
LVGO
3947
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $426K | ﹤0.01% |
14,933
+11,975
| +405% | +$310K |
|
|
HAPN
3948
Happen Inc
HAPN
$2.21B
| $425K | ﹤0.01% |
54,203
-5,134
| -9% | -$57.2K |
|
|
SA
3949
CALL
Seabridge Gold
SA
$2.78B
| $425K | ﹤0.01% |
46,100
+27,800
| +152% | +$329K |
|
3950
Piper Sandler
PIPR
$5.12B
| $424K | ﹤0.01% |
33,572
-2,836
| -8% | -$50.5K |
|
Similar funds
Citigroup's Q1 2020 Portfolio in Review
As of Q1 2020, Citigroup held 8,003 positions worth $111B, down 20% from $138B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Citigroup's Q1 2020 filing shows 244 new, 3,316 increased, 3,513 reduced and 342 closed positions. Its largest new stake was Direxion Flight to Safety Strategy ETF: 100,000 shares worth $5.01M. The largest sale was Invesco QQQ Trust, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 6.7% of assets, up from 6.7% a quarter earlier, followed by Healthcare and Financials.
- Citigroup's largest Q1 2020 buy was Direxion Flight to Safety Strategy ETF: 100,000 shares worth $5.01M.
- Citigroup added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q1 2020, an estimated $633M increase.
- Citigroup's biggest Q1 2020 reduction was Invesco QQQ Trust, cutting an estimated $1.17B.
- Citigroup fully exited Zayo Group Holdings, Inc. in Q1 2020, selling an estimated $327M.
- Citigroup's ten largest holdings make up 24% of its $111B portfolio in Q1 2020.
- Citigroup opened 244 new positions and closed 342 in Q1 2020.
- Citigroup's portfolio value fell 20% quarter-over-quarter to $111B.
Based on Citigroup's 13F filing for Q1 2020, filed 12 May 2020.